Login
Request a demo

Author: linneaP

Categories
Uncategorized

What can Europeans learn from Canada for the upcoming EU joint HTA, Gabriel Tremblay?

Dive into the future of healthcare collaboration in Europe with an eye-opening discussion on the upcoming EU joint Health Technology Assessment (HTA). With the European Commission’s recent announcement, the healthcare landscape is poised for a significant shift, yet questions linger about its implementation, timing, and integration into national frameworks across EU member states. How will this compare to Canada’s pioneering joint HTA process, established in the early 2000s, which harmonized evaluations across its provinces?

Join Dr. Stefan Walzer and Gabriel Tremblay, a renowned Canadian Health Economic Expert, as they explore the invaluable lessons European healthcare systems can draw from Canada’s experience. This conversation promises to shed light on critical aspects of reimbursement and market access that could shape the future of healthcare in Europe.

Listen to the podcast: here

Categories
Uncategorized

Digital Health Care is already fully utilized in the US, isn’t it?

Step into the future of healthcare with Dr. Stefan Walzer and Kate Claessens, on this podcast episode where we dissect the pulse of digital health in the USA. From public acceptance to intricate reimbursement pathways, and the potential shifts under the Biden administration, we’re covering the essentials you need to know. How does digital healthcare navigate the complex US reimbursement landscape? What strategic moves should you anticipate next?

Join us as we delve into these critical discussions, offering more expert insights with the practical experience of Anna Forsythe, a titan in global product commercialization and strategic drug development from Purple Squirrel Economics. Whether you’re eyeing the US market for your digital health solutions or simply keen on the latest in healthcare innovation, this episode is your roadmap to understanding and conquering one of the world’s most lucrative markets.

Listen to the podcast: here

Categories
Uncategorized

Does the Italian reimbursement pathway allow for innovative drugs being highly priced, Dr. Stefano Capri and Dr. Entela Xoxi?


Venture into the heart of Italy’s healthcare system with Dr. Stefan Walzer and two Italian experts, Prof. Dr. Stefano Capri and Dr. Entela Xoxi, as they unravel the complexities of the Italian reimbursement landscape. This episode takes you behind the scenes of Italy’s innovation pathway, exploring what this evolution means for the pharmaceutical industry and health care accessibility. Is negotiating a premium price for new treatments as straightforward as it seems? Join us for an enlightening discussion that sheds light on these questions and more. Don’t miss out on the opportunity to deepen your understanding of global market access strategies. Subscribe now on your favorite podcast platform or listen directly on our website. Stay ahead of the curve with MArS, your go-to bi-weekly podcast for exclusive insights into market access and pricing strategies.

Listen to the podcast: here

Categories
Uncategorized

How do innovations reach patients in German hospitals, Dr. Sebastian Casu?

Unlock the secrets to healthcare innovation in this podcast episode as Dr. Stefan Walzer and Dr. Sebastian Casu, a renowned medical doctor and influencer, delve into the pivotal role of NUBs, OPS, and DRG values in patient care. Wondering how groundbreaking innovations bypass administrative hurdles to reach those in need? Or what the future holds for digital health care in Germany? Our experts continue the riveting discussion from Episode 9, featuring insights from Willi Wöllner, to explore the cutting-edge of inpatient market access and digital healthcare advancements. Don’t let this conversation pass you by – tune in now for a deep dive into bedside innovation and the digital transformation of healthcare. Be part of the forefront of market access dialogue with MArS, the first and only bi-weekly podcast dedicated to market access insights.

Listen to the podcast: here

Categories
Uncategorized

How does hospital funding work in Germany, Willi Wöllner?

Dive into the intricate world of reimbursement within the German hospital setting with Dr. Stefan Walzer and experienced hospital administrator Willi Wöllner as they unravel the complexities of inpatient care negotiations. Ever wondered how hospitals and health insurance funds hash out annual budgets? Or what a NUB is and its significance in these discussions? Perhaps you’re curious if industry really can take part in this process. Our experts are peeling back the layers of the business side of hospital operations, setting the stage for an enlightening follow-up on the medical perspective with Dr. Sebastian Casu in the next episode. Don’t miss this insightful journey into the heart of healthcare financing. Subscribe now on your favorite podcast platform and connect with the cutting-edge insights from MArS Market Access and Pricing Strategy.

Listen to the podcast: here